12/09/2024
4:42 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024
8:30 PM | Boxer Capital Management, LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
12/05/2024
3:21 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
6:06 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
3:47 PM | Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
8:31 PM | Boxer Capital Management, LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
11/14/2024
4:52 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
11/14/2024
4:47 PM | NEXTECH VI ONCOLOGY SCSP (Filed by)
Tyra Biosciences (Subject)
| Form SC 13G/A | |
11/14/2024
3:34 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Tyra Biosciences (Subject)
| Form SC 13G/A | |
11/13/2024
5:04 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13G/A | |
11/08/2024
3:43 PM | Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
6:24 PM | Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
5:18 PM | Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
3:22 PM | Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
4:15 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/28/2024
6:00 AM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
7:01 AM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
8:15 PM | Boxer Capital Management, LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
10/22/2024
7:47 PM | Boxer Capital Management, LLC (Reporting)
Tyra Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2024
7:49 PM | Boxer Capital Management, LLC (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
4:11 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
10/22/2024
4:13 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
4:04 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:23 PM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
7:12 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
4:51 PM | Harris Todd (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024
8:59 PM | Boxer Capital, LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
10/15/2024
6:22 PM | Boxer Asset Management Inc. (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
10/02/2024
4:38 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
5:44 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
5:24 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
3:49 PM | Harris Todd (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:42 PM | Harris Todd (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
2:56 PM | Harris Irrevocable Trust 2 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
2:59 PM | Harris Irrevocable Trust 3 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:05 PM | Harris Irrevocable Trust 4 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
2:27 PM | Harris Irrevocable Trust 1 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/17/2024
4:12 PM | Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:15 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:49 PM | Tyra Biosciences (Issuer)
Warner Douglas J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
We recommended Palantir in 2021, now we’re recommending this... (Ad) My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol |
09/10/2024
3:53 PM | Tyra Biosciences (Issuer)
Warner Douglas J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
4:50 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
4:55 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
4:18 PM | Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:10 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
2:08 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
5:26 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:30 PM | Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:30 PM | MORE ROBERT J (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:30 PM | KAPLAN GILLA (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:30 PM | Subramony Siddarth (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:30 PM | Tyra Biosciences (Issuer)
Verjee Rehan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:30 PM | Simson Jake (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:46 PM | Rothenberg Stephen Michael (Reporting)
Tyra Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/09/2024
3:48 PM | Rothenberg Stephen Michael (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:49 PM | Moran Susan (Reporting)
Tyra Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/09/2024
3:49 PM | Moran Susan (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:08 PM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2024
11:15 PM | Tyra Biosciences (Filer)
| Form EFFECT | |
04/05/2024
3:20 PM | Tyra Biosciences (Filer)
| Form PRE 14A | |
03/19/2024
6:58 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:01 PM | Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:38 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:33 PM | Tyra Biosciences (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/19/2024
3:35 PM | Tyra Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/13/2024
4:46 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:19 AM | FMR LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13G/A | |
03/08/2024
4:38 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:40 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:58 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
8:00 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
8:24 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Tyra Biosciences (Subject)
| Form SC 13G/A | |
02/09/2024
6:26 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
9:05 AM | FMR LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13G/A | |
02/08/2024
4:10 PM | Boxer Capital, LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
02/08/2024
4:16 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
4:09 PM | Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
7:22 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
7:23 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
3:56 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2024
3:40 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
02/05/2024
5:05 AM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
4:04 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
3:47 PM | Harris Todd (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
4:24 PM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2023
8:00 AM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
